OUR
BUSINESS
BUSINESS THAT CHANGES LIVES
Science Valley is a multicentric management company, unprecedented in the world, which offers intelectual and technical scientific services in the field of intelligence in clinical research and R&D services for the development of pharmaceutical drugs, raw materials, new treatments, high medical-scientific education, surgical procedures, vaccines, cost-effectiveness studies and devices for human health.
OUR PURPOSE
Our purpose is to save life by providing maximum improvement for patients with severe deaseses, supporting the pharma industry of global research, the academic and health professionals community (technical evolution), and the development of science in the world – as well as improving the quality of life of people, enhancing theHID (Human Development Index).
OUR MISSION
Offer intellectual, technical & scientific development for new drugs and treatments, delivering high medical and scientific education, cutting-edge technology with a multi-task team, contributing to the global well-being.
OUR VISION
Become the best and greatest Multicenter International Research Institute (MIRI), fully operating and recruiting in Brazil, USA, Latin America, Asia and Europe, turning into the preferential partner for local and international sponsors of study design and activities arising, in all specialty areas, collaborating with physicians, healthcare institutions, researchers and patients.
OUR VALUES
Humanization (in patients care | Ethics & Transparency (technical-scientific) | Respect (to partners, employees and society).
FOCUS ON THE PATIENT
To perform intelligence services in clinical research and R&D, Science Valley offers sponsors (public and private, national or international institutions) that are responsible for innovation in healthcare in Brazil and in the world. The company is an innovative proposal, focused on the development of study design, customization and innovation of the sophisticated integrated processes of clinical studies, focusing on patients whom seek treatment for severe diseases.
TRACK RECORD
Science Valley has ensured, so far, a recognized track record of excellence, technical respectability and rigorous operational management standards, which today has more than dozens of projects in its portfolio, whether sponsored by big pharmas, governmentally subsidized (CNPQ) or self-sponsored.
PORTFÓLIO
The Science Valley Portfolio(1) contains numerous ongoing studies in several areas of interest:
8
Diabetes
3
Pain (post- surgery)
1
Neuropathya
1
Rare Diseases
2
Multiple Sclerosis
1
Anestesic
53
Severe Cardiovacular Diseases
25
Covid 19
(1) August, 2022